Linkage to Care - Part I

University of North Carolina, Chapel Hill35 enrolled

Overview

This first phase of a two-phase study involves three components: 1. Review of existing linkage-to-care protocols and sources of referrals for care; 2. Semi-structured telephone or face-to-face interviews with a minimum of two personnel per site who are associated with linkage to medical care. (Preference will be given to personnel with direct experience in linkage to care); and 3. Structured observations of referral sessions.

Study Type

OBSERVATIONAL

Enrollment

Conditions

HIV

Eligibility

Sex: ALLHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Component 1: Documents identified by clinical site personnel as pertaining to post-test counseling, linkage to care, or standard operating procedures addressing post-test counseling and linkage to care. * Component 2: Persons employed by one of the AMTUs or an identified linkage-to-care partner and work as clinical staff or a case-manager or is a person familiar to linkage to care; or persons involved in posttest counseling and linkage-to-care processes. Clinical staff and case managers are chosen based on direct experience in the assistance of HIV seropositive youth obtaining medical care. This definition includes, but is not limited to, physicians, nurses, psychologists, social workers, and case managers (who may have diverse professional backgrounds). * Component 3: All AMTU sites will be included. Exclusion Criteria: * Component 1: No a priori exclusions. * Component 2: No a priori exclusions. * Component 3: No a priori exclusions.

Locations (7)

Children's National Medical Center

Washington D.C., District of Columbia, United States

Childrens Diagnostic&Treatment Center

Fort Lauderdale, Florida, United States

University of Miami School of Medicine

Miami, Florida, United States

Mount Sinai Medical Center

Manhattan, New York, United States

Outcomes

Primary Outcomes

Describe and evaluate community screening standards and practices.

Time frame: 1 year

Describe and evaluate the relationships of screening venues with care-providing venues.

Time frame: 1 year

Describe and evaluate referral and intake protocols.

Time frame: 1 year

Describe and evaluate care adherence support (including support from both clinical and non-clinical sources).

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.